# Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)

> **NCT04597437** · PHASE2 · RECRUITING · sponsor: **George Washington University** · enrollment: 74 (estimated)

## Conditions studied

- Dengue Fever

## Interventions

- **DRUG:** Zanamivir
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04597437
- **Lead sponsor:** George Washington University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-15
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04597437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04597437, "Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04597437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*